BASIS OF PRESENTATION (Details Narrative) - USD ($) |
6 Months Ended | 12 Months Ended | |||||
|---|---|---|---|---|---|---|---|
Oct. 07, 2025 |
Oct. 02, 2025 |
Sep. 05, 2025 |
Dec. 28, 2024 |
Jun. 27, 2026 |
Jun. 28, 2025 |
Dec. 27, 2025 |
|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||
| Net loss | $ 2,900,000 | ||||||
| Net cash outflows from operations | 5,142,502 | $ 7,572,770 | |||||
| Damages paid value | $ 19,700,000 | $ 19,700,000 | $ 24,700,000 | $ 19,700,000 | |||
| Awarded value | 23,000,000.0 | $ 19,700,000 | |||||
| Litigation settlement, gain | 5,100,000 | ||||||
| Payments for legal settlements | 23,000,000.0 | 51,200,000 | |||||
| Professional fees | 1,150,000 | ||||||
| Cash and cash equivalents | 24,876,516 | $ 36,350,083 | |||||
| Remaining performance obligation | 40,300,000 | ||||||
| Revenue, remaining performance obligation, amount subject to cancellation | $ 8,800,000 | ||||||
| Loan Agreements [Member] | |||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||
| Payments for legal settlements | $ 24,200,000 | ||||||
| X | ||||||||||
- Definition Revenue remaining performance obligation amount subject to cancellation. No definition available.
|
| X | ||||||||||
- Definition Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain from litigation settlement for amount awarded from other party. Excludes claims within an insurance entity's normal claims settlement process. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of damages awarded to the plaintiff in the legal matter. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of damages paid to the plaintiff in the legal matter. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of cash paid for the settlement of litigation or for other legal issues during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of transaction price allocated to performance obligation that has not been recognized as revenue. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|